Quantitative plasma DNA analysis in Parkinson's disease

Neuroscience Letters

Volumn 452, Issue 1, 2009, Pages 5-7

  Scalzo, Paula Luciana ^a   Ikuta, Nilo ^b   Cardoso, Francisco ^a   Regner, Andrea ^b   Teixeira, Antônio Lúcio ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Luteran University of Brazil   (Brazil)

^c Neuropsychiatric Branch   (Brazil)

Author keywords

Biomarker; Free DNA; Parkinson's disease

Indexed keywords

BIOLOGICAL MARKER; DNA;

ADULT; AGED; ARTICLE; CELL FREE SYSTEM; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; DNA; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; PLASMA; STATISTICS, NONPARAMETRIC;

EID: 59549086270     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.01.031     Document Type: Article

References (29)

1. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-Van Dillen P.M., and Van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990) 495-503
2. Brucki S.M.D., Nitrini R., Caramelli P., Bertolucci P.H.F., and Okamoto I.H. Sugestões para o uso do Mini-Exame do Estado Mental no Brasil. Arq. Neuropsiquiatr. 61 (2003) 777-781
3. Calne D. A definition of Parkinson's disease. Parkinsonism Relat. Disord. 11 (2005) S39-40
4. Catarino R., Ferreira M.M., Rodrigues H., Coelho A., Nogal A., Sousa A., and Medeiros R. Quantification of free circulating tumor DNA as a diagnostic marker of breast cancer. DNA Cell Biol. 27 (2008) 415-421
5. da Rocha A.B., Zanoni C., de Freitas G.R., André C., Himelfarb S., Schneider R.F., Grivicich I., Borges L., Schwartsmann G., Kaufmann M., and Regner A. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J. Neurotrauma 22 (2005) 966-977
6. de Lau L., and Breteler M. Epidemiology of Parkinson's disease. Lancet Neurol. 5 (2006) 525-535
7. Eriksen J.L., Wszolek Z., and Petrucelli L. Molecular pathogenesis of Parkinson disease. Arch. Neurol. 62 (2005) 353-357
8. Fahn S., and Elton R. Unified Parkinson's disease rating scale. In: Fahn S., Marsden Cd, Caine Db, and Goldstein M. (Eds). Recent Developments in Parkinson's Disease vol. 2 (1987), Macmillan Health Care information, Florham Park pp. 153-63, 293-304
9. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
10. Henley S.M., Bates G.P., and Tabrizi S.J. Biomarkers for neurodegenerative diseases. Curr. Opin. Neurol. 18 (2005) 698-705
11. Herrmann M., Curio N., Jost S., Grubich C., Ebert A.D., Fork M.L., and Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J. Neurol. Neurosurg. Psychiatry 70 (2001) 95-100
12. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
13. Holland P.M., Abramson R.D., Watson R., and Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7276-7280
14. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 42 (1992) 1142-1146
15. Hughes A.J., Ben-Shlomo Y., Daniel S.E., and Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 57 (2001) S34-38
16. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
17. Kim S.W., Ko H.S., Dawson V.L., and Dawson T.M. Recent advances in our understanding of Parkinson's disease. Drug Discov. Today 2 (2005) 427-433
18. A. Kummer, F. Cardoso, A.L. Teixeira, Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease, Parkinsonism Relat. Disord., in press, PMID: 18514013.
19. Lam N.Y., Rainer T.H., Chan L.Y., Joynt G.M., and Lo Y.M. Time course of early and late changes in plasma DNA in trauma patients. Clin. Chem. 49 (2003) 1286-1291
20. Lo Y.M., Rainer T.H., Chan L.Y., Hjelm N.M., and Cocks R.A. Plasma DNA as a prognostic marker in trauma patients. Clin. Chem. 46 (2000) 319-323
21. Lo Y.M., Tein M.S., Lau T.K., Haines C.J., Leung T.N., Poon P.M., Wainscoat J.S., Johnson P.J., Chang A.M., and Hjelm N.M. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62 (1998) 768-775
22. Michell A.W., Lewis S.J., Foltynie T., and Barker R.A. Biomarkers and Parkinson's disease. Brain 127 (2004) 1693-1705
23. Rainer T.H., Wong L.K., Lam W., Yuen E., Lam N.Y., Metreweli C., and Lo Y.M. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin. Chem. 49 (2003) 562-569
24. Savola O., Pyhtinen J., Leino T.K., Siitonen S., Niemelä O., and Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J. Trauma 56 (2004) 1229-1234
25. Schaf D.V., Tort A.B., Fricke D., Schestatsky P., Portela L.V., Souza D.O., and Rieder C.R. S100B and NSE serum levels in patients with Parkinson's disease. Parkinsonism Relat. Disord. 11 (2005) 39-43
26. Swarup V., and Rajeswari M.R. Circulating (cell-free) nucleic acids - a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 581 (2007) 795-799
27. Yurgel V.C., Ikuta N., da Rocha A.B., Lunge V.R., Schneider R.F., Fonseca A.S.K., Grivicich I., Zanoni C., and Regner A. Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males. J. Neurotrauma 24 (2007) 1172-1181
28. Zemlan F.P., Jauch E.C., Mulchahey J.J., Gabbita S.P., Rosenberg W.S., Speciale S.G., and Zuccarello M. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947 (2002) 131-139
29. Zhong X.Y., Hahn S., Kiefer V., and Holzgreve W. Is the quantity of circulatory cell-free DNA in human plasma and serum samples associated with gender, age and frequency of blood donations? Ann. Hematology 86 (2007) 139-143